Resultados da busca - David Nathanson
- Mostrando 1 - 20 resultados de 26
- Ir para a próxima página
-
1
Insights into the mechanisms of lymph node metastasis por David Nathanson
Publicado em 2003Revisão -
2
-
3
Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes por David Nathanson, S., Leonard-Murali, Shravan, Burmeister, Charlotte, Susick, Laura, Baker, Patricia
Publicado em 2020Texto -
4
-
5
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality por Jan W. Eriksson, Johan Bodegård, David Nathanson, Marcus Thuresson, Thomas Nyström, Anna Norhammar
Publicado em 2016Artigo -
6
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 200... por Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, Jan W. Eriksson, David Nathanson
Publicado em 2016Artigo -
7
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and se... por Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson
Publicado em 2016Artigo -
8
Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type... por Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson
Publicado em 2017Artigo -
9
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study... por Anna Norhammar, Johan Bodegård, Thomas Nyström, Marcus Thuresson, David Nathanson, Jan W. Eriksson
Publicado em 2019Artigo -
10
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety por David Nathanson, Bengt Ullman, Ulrika Löfström, Anders Hedman, Mats Frick, Åke Sjöholm, Thomas Nyström
Publicado em 2012Artigo -
11
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive cont... por David Nathanson, Ann‐Marie Svensson, Mervete Miftaraj, Stefan Franzén, Jan Bolinder, Katarina Eeg‐Olofsson
Publicado em 2021Artigo -
12
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study por Henrik Falhammar, Jonatan D. Lindh, Jan Calissendorff, Shermineh Farmand, Jakob Skov, David Nathanson, Buster Mannheimer
Publicado em 2018Artigo -
13
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks i... por Viveca Ritsinger, Johan Bodegård, Robin Kristófi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan W. Eriksson, Anna Norhammar
Publicado em 2023Artigo -
14
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study por Robin Kristófi, Johan Bodegård, Anna Norhammar, Marcus Thuresson, David Nathanson, Thomas Nyström, Kåre I. Birkeland, Jan W. Eriksson
Publicado em 2021Artigo -
15
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization por Vladimer Darsalia, Sansan Hua, Martin Larsson, Carina Mallard, David Nathanson, Thomas Nyström, Åke Sjöholm, Maria E. Johansson, Cesare Patrone
Publicado em 2014Artigo -
16
Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes por Charles D. Callery, Alistair J. Cochran, Denise J. Roe, William V. Rees, S. David Nathanson, Jacqueline Benedetti, Robert M. Elashoff, Donald L. Morton
Publicado em 1982Artigo -
17
-
18
An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis por Gabi Tarcic, Shlomit Boguslavsky, Jean Wakim, Tai Kiuchi, A.H. Liu, Felicia Reinitz, David Nathanson, Takamune Takahashi, Paul S. Mischel, Tony Ng, Yosef Yarden
Publicado em 2009Artigo -
19
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin por Grażyna Lietzau, William Davidsson, Claes‐Göran Östenson, Fausto Chiazza, David Nathanson, Hiranya Pintana, Josefin Skogsberg, Thomas Klein, Thomas Nyström, Vladimer Darsalia, Cesare Patrone
Publicado em 2018Artigo -
20
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Cancer
Breast cancer
Population
Biology
Cancer research
Confidence interval
Disease
Engineering
Environmental health
Mechanical engineering
Stroke (engine)
Cohort
Hazard ratio
Pathology
Proportional hazards model
Dapagliflozin
Gene
Genetics
Insulin
Metastasis
Myocardial infarction
Oncology
Pediatrics
Pharmacology
Receptor